CD19 and hepatocellular carcinoma: Within the high-HCC-risk population, significant differences in CD8+, CD19+ and NK cell levels were found between male and female patients, patients in TNM stages I-II and stages III-IV, patients with and without extrahepatic metastasis, and patients with and without HBV infection (all P < 0.05).